Thursday, October 15, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 22, 2026

Is This the Perfect Age to Start Collecting Social Security?

View original at nasdaq.com
Is This the Perfect Age to Start Collecting Social Security? Key Points The average retirement age in the U.S. is currently 62. Social Security’s full retirement age is 67 for those born in 1960 or later…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Postponing Social Security benefits until age 70 maximizes your monthly benefit amount

    60% confidence

  • A handful of little-known Social Security secrets could help ensure a boost in retirement income, with one easy trick potentially paying as much as $23,760 more each year

    60% confidence

  • There is no one-size-fits-all answer for the perfect age to begin collecting Social Security

    60% confidence

  • There's a gap between the expected age of retirement (67) and the actual age (62), often due to health issues, caregiving needs, and layoffs

    60% confidence

  • Someone with health complications and a shorter life expectancy is more likely to maximize what they get from the program with an early claim

    60% confidence

  • By retiring earlier, you reduce the amount your family will collect in survivors benefits after your passing

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com
Is This the Perfect Age to Start Collecting Social Security? — Source | Via News | ViaNews Market